This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.
Dashboard: Filter Bricks
Main page content
Displaying results 1 - 2 of 2
Publication ID: SMA15-4925
Published:
Publication ID: SMA12-4682
Published:
This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.